secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001493152-24-001771
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma updates corporate presentation; no specific disclosures
-------------------------------------------------------------------------

- Filed an updated corporate presentation dated January 9, 2024, for use at conferences and investor meetings.
- No financial results, pipeline updates, or material agreements were disclosed in the filing.
- The presentation is attached as Exhibit 99.1 but its content is not summarized in the 8-K.
- Ticker: MTNB (NYSE American). Event is a routine Regulation FD disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224001771/0001493152-24-001771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224001771/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer